Regression of Multiple Meningiomas after Discontinuation of Chronic Hormone Therapy: A Case Report
| Autor: | Maryam N. Shahin, Stephen G. Bowden, Nasser K. Yaghi, Jacob H. Bagley, Seunggu J. Han, Elena V. Varlamov, Marjorie R. Grafe, Justin S. Cetas |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Journal of Neurological Surgery Reports, Vol 82, Iss 04, Pp e38-e42 (2021) |
| Druh dokumentu: | article |
| ISSN: | 2193-6358 2193-6366 |
| DOI: | 10.1055/s-0041-1735553 |
| Popis: | Introduction Meningiomas are more common in females and frequently express progesterone and estrogen receptors. Recent studies have revealed a high incidence of meningiomas in situations in which estrogen/progesterone levels are increased such as pregnancy, gender reassignment therapy, and fertility treatment. While the relationship remains unclear and controversial, these findings suggest exposure to high levels of endogenous or exogenous hormones may increase the risk of developing a meningioma. Patients and Methods A 40-year-old female with a history of endometriosis treated with chronic progesterone therapy presented with a visual deficit and was found to have multiple meningiomas, which regressed after cessation of exogenous progesterone. Conclusion A history of chronic hormone therapy should be included when evaluating patients diagnosed with meningiomas, particularly at a younger age and with multiple meningiomas. Cessation of exogenous progesterone resulting in regression of meningiomas suggests a direct action of progesterone on growth. Future studies are warranted to better elucidate this relationship. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|